CEOCast Where Wall Street Listens

MICHAEL WACHS CEOCAST NEWS

Junior oil and gas producer, Patch International Inc. (OTCBB: PTCH),
updated shareholders on its operating activities. Regarding its
Rich/Rumsey, Alberta property, a test well was plugged back to a
secondary formation after the primary target did not produce results.
The company will review results and make a final analysis regarding the
testing of this well or the drilling of a well at a new location. For
its Halkirk, Alberta property, a test well was frac'd where the company
is awaiting flow results from the operator. The seismic program for the
Red Deer (Joffre), Alberta property has been completed and is currently
being interpreted to determine the location of the first well which
will commence drilling in mid-fall. Regarding the Atlee-Buffalo Area,
Alberta property, Patch is awaiting advice from the operator as to the
drill date of the well. The company is also awaiting advice from the
operator as to the drill dates of wells located in the Lloydminster
Area, Alberta property. The stock ended last week unchanged at $1.25.

CEOCAST

Shares of Advanced Cell Technology, Inc. (OTCBB: ACTC), a company
applying stem cell technology in the emerging field of regenerative
medicine, could receive a boost if the company is able to close a $10
million financing announced in mid-August. The proceeds of the
financing are expected to be used to fund working capital, including
costs associated with advancing the technology it expects to acquire in
its pending acquisition of Mytogen to Phase II clinical trials. If the
company is able to complete the Mytogen acquisition, it has the
potential to significantly change investors' perceptions, as Mytogen is
one of the few stem cell companies currently in the clinic. ACTC
currently has a market capitalization of less than $30 million, far
less than other stem cell companies that are still in early stages of
clinical development. Note that the proceeds would also likely be used
to advance several promising preclinical programs in the areas of
Retinal Pigment Epithelial cells for diseases of the eye, Hemangioblast
cells for the treatment of blood disorders and cardiac disease, and
Dermal cells for skin damage such as burns, wound repair, etc. All
represent significant market opportunities. Shares ended the week at
$0.35, up 2 cents.

CEOCAST - Multiband
Corporation (NASDAQ: MBND), a company that together with its
subsidiaries, provides software and integrated billing services,
including voice, data, and video services, said last week that
DirecTECH Holding Company, Inc., has entered into a agreement with its
primary lender whereby DTHC and its subsidiaries have extended its loan
agreement until October 10, 2008. Pursuant to the extension of the
agreement, DTHC has reduced its indebtedness with the lender from
approximately $15 million to approximately $12 million and revised
certain loan covenants. The reason this is significant for Multiband is
that the company entered into an agreement to acquire a majority stake
in DirecTECH Southwest and has already completed the acquisition of a
majority interest in Michigan Microtech, a DirecTECH subsidiary. Since
DirecTECH would be a minority owner of both entities, its relationship
with its lender could impact operations. This agreement should reduce
concerns about debt-related issues. Shares fell by $0.17 for the week,
to close at $0.93.

MICHAEL WACHS CEOCAST NEWS - The
conference schedule for the week looks to be very active. The week will
get off to a busy start on Monday with a four day Bear Stearns 21st
Annual Media Conference in Palm Beach, Florida and a three day Credit
Suisse Group Communications Equipment & Networking Conference in
Boston. The Deutsche Bank 2008 Hospitality & Gaming Conference in
Boston, the three day Lehman Brothers High Yield Bond and Syndicated
Loan Conference in Florida, and the two day UBS European Technology
Services Conference in London, will all take place on Wednesday. Bear
Stearns' London Health Care Conference in London and the two-day
Wachovia Small Cap Seminar in Utah, will conclude an active week of
conferences.

CEOCAST MICHAEL WACHS PROFILE - MICHAEL WACHS CEOCAST BUSINESS - MICHAEL WACHS CEOCAST BUSINESS